Loading content

Richard Smith

Deputy Pro-Vice Chancellor and Professor of Health Economics

01392 72 6076

Medical School Building F.06

Medical School Building, St Luke's Campus, Magdalen Road, Exeter, EX1 2LU, UK

Overview

Richard Smith is inaugural Deputy Pro-Vice Chancellor for the University of Exeter Medical School, and Professor of Health Economics. He was previously at the London School of Hygiene and Tropical Medicine, where he served as Head of the Department of Global Health & Development from 2008-2011, and as Dean of the Faculty of Public Health & Policy from 2011-2018.

Richard has experience with a wide range of economic methods, including micro-, macro-, behavioural-, and political-economic techniques, applied to various areas, from health outcome assessment to antibiotic resistance. In the last decade he has especially pioneered the macro-economic modelling of communicable and non-communicable diseases, and the economic analysis of the impact of trade and trade agreements on health and health care across a range of areas.

Richard has received research funding in excess of £40m, and has more than 200 publications. He is a senior Editor for Social Science & Medicine, and has had previous editorial responsibilities for journals including Health Economics, Journal of Public Health and Globalization and Health. He has been member and chair of various research funding panels, and expert advisor for numerous organisations, including WHO, WTO, World Bank, OECD and various countries.

Qualifications

1990 BA Economics, University of York
1991 MSc Health Economics, University of York
2007 PhD Health Economics, University of East Anglia

Grants/Funding:

Walls H, Smith RD, Johnston D. Do agricultural input subsidies on staples reduce dietary diversity? Drivers of Food Choice Competitive Grants Program funded by the Bill & Melinda Gates Foundation and the UK Department for International Development, 2016-2018, £299,424.
Smith RD, Milson P. Assessing health impacts of the investor-state dispute settlement provision in contemporary trade and investment agreements: Case-studies of tobacco control, access to essential medicines and environmental health. Wellcome Trust Society & Ethics Doctoral Studentship for Penelope Milsom, 2016-2019 £105,223.
Dangour AD, Haines A, Smith RD, Green R, Cornelsen L, Kadiyala S, Knai C, Leon D, Waage J. Sustainable and Healthy Food Systems (SHEFS) Wellcome Trust, 2017-2022, £5,000,000.
White M, Smith RD, Cummins S, Rutter H, Rayner M, Scarborough P, Briggs A, Harrington R, Adams J, Mytton O. Evaluation of the impacts of the UK Treasury Soft Drinks Industry Levy (SDIL). NIHR, £1,500,000, 2017-2020.

Research

Publications

Key publications | Publications by category | Publications by year

Publications by category

Journal articles

Roope LSJ, Smith RD, Pouwels KB, Buchanan J, Abel L, Eibich P, Butler CC, Tan PS, Walker AS, Robotham JV, et al (In Press). The challenge of antimicrobial resistance: What economics can contribute. Science, 364(6435). Abstract. Author URL.

Tarp Jenson H, Keogh-Brown MR, Shankar B, Aekplakorn W, Basu S, Cuevas S, Dangour AD, Gheewala SH, Green R, Joy EJM, et al (2019). Palm oil and dietary change: Application of an integrated macroeconomic, environmental, demographic, and health modelling framework for Thailand. Food Policy (Elsevier)

Suzana M, Walls H, Smith R, Hanefeld J (2018). Achieving universal health coverage in small island states: could importing health services provide a solution?. BMJ Global Health, 3(1), e000612-e000612.

Smith RD, Cornelson L, Quirmbach D, Jebb SA, Marteau TM (2018). Are sweet snacks more sensitive to price increases than sugar-sweetened beverages: analysis of British food purchase data. BMJ Open Full text.

Quirmbach D, Cornelsen L, Jebb SA, Marteau T, Smith R (2018). Effect of increasing the price of sugar-sweetened beverages on alcoholic beverage purchases: an economic analysis of sales data. Journal of Epidemiology and Community Health, jech-2017-209791-jech-2017-209791. Full text.

Suzana M, Walls H, Smith R, Hanefeld J (2018). Evaluation of public subsidy for medical travel: does it protect against household impoverishment?. International Journal for Equity in Health, 17(1).

Marten R (2018). How states exerted power to create the Millennium Development Goals and how this shaped the global health agenda: Lessons for the sustainable development goals and the future of global health. Global Public Health, 1-16.

Waage J, Cornelsen L, Dangour AD, Green R, Häsler B, Hull E, Johnston D, Kadiyala S, Lock K, Shankar B, et al (2018). Integrating Agriculture and Health Research for Development: LCIRAH as an Interdisciplinary Programme to Address a Global Challenge. Global Challenges, 1700104-1700104.

Cornelsen L, Smith RD (2018). Viewpoint: Soda taxes – Four questions economists need to address. Food Policy, 74, 138-142.

Cornelson L, Mytton OT, Adams J, Gasparrini A, Iskander D, Knai C, Petticrew M, Scott C, Smith RD, Thompson C, et al (2017). Change in non-alcoholic beverage sales following a 10-pence levy on sugar-sweetened beverages within a national chain of restaurants in the UK: interrupted time series analysis of a natural experiment. BMJ Full text.

Walls HL, Cornelsen L, Lock K, Smith RD (2016). How much priority is given to nutrition and health in the EU Common Agricultural Policy?. FOOD POLICY, 59, 12-23. Author URL.

Smith R, Irwin R (2016). Measuring success in global health diplomacy: lessons from marketing food to children in India. GLOBALIZATION AND HEALTH, 12 Author URL.

Noree T, Hanefeld J, Smith R (2016). Medical tourism in Thailand: a cross-sectional study. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 94(1), 30-36. Author URL.

Keogh-Brown MR, Jensen HT, Arrighi HM, Smith RD (2016). The Impact of Alzheimer's Disease on the Chinese Economy. EBIOMEDICINE, 4, 184-190. Author URL.

Walls HL, Vearey J, Modisenyane M, Chetty-Makkan CM, Charalambous S, Smith RD, Hanefeld J (2016). Understanding healthcare and population mobility in southern Africa: the case of South Africa. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 106(1), 14-15. Author URL.

Sheppard P, Smith R (2016). What students want: using a choice modelling approach to estimate student demand. JOURNAL OF HIGHER EDUCATION POLICY AND MANAGEMENT, 38(2), 140-149. Author URL.

Kinghorn P, Robinson A, Smith RD (2015). Developing a Capability-Based Questionnaire for Assessing Well-Being in Patients with Chronic Pain. SOCIAL INDICATORS RESEARCH, 120(3), 897-916. Author URL.

Coast J, Smith RD (2015). Distributional Considerations in Economic Responses to Antimicrobial Resistance. PUBLIC HEALTH ETHICS, 8(3), 225-237. Author URL.

Walls HL, Smith RD, Drahos P (2015). Improving regulatory capacity to manage risks associated with trade agreements. GLOBALIZATION AND HEALTH, 11 Author URL.

Lunt N, Exworthy M, Hanefeld J, Smith RD (2015). International patients within the NHS: a case of public sector entrepreneurialism. SOCIAL SCIENCE & MEDICINE, 124, 338-345. Author URL.

Shemilt I, Marteau TM, Smith RD, Ogilvie D (2015). Use and cumulation of evidence from modelling studies to inform policy on food taxes and subsidies: biting off more than we can chew?. BMC PUBLIC HEALTH, 15 Author URL.

Hanefeld J, Lunt N, Smith R, Horsfall D (2015). Why do medical tourists travel to where they do? the role of networks in determining medical travel. SOCIAL SCIENCE & MEDICINE, 124, 356-363. Author URL.

Marten R, Hanefeld J, Smith R (2014). Commission on Global Governance for Health: what about power?. LANCET, 383(9936), 2207-2207. Author URL.

Lunt N, Horsfall D, Smith R, Exworthy M, Hanefeld J, Mannion R (2014). Market size, market share and market strategy: three myths of medical tourism. POLICY AND POLITICS, 42(4), 597-614. Author URL.

Noree T, Hanefeld J, Smith R (2014). UK medical tourists in Thailand: they are not who you think they are. GLOBALIZATION AND HEALTH, 10 Author URL.

Hanefeld J, Smith R, Horsfall D, Lunt N (2014). What Do We Know About Medical Tourism? a Review of the Literature with Discussion of its Implications for the UK National Health Service as an Example of a Public Health Care System. JOURNAL OF TRAVEL MEDICINE, 21(6), 410-417. Author URL.

Smith R, Lagarde M, Blaauw D, Goodman C, English M, Mullei K, Pagaiya N, Tangcharoensathien V, Erasmus E, Hanson K, et al (2013). Appealing to altruism: an alternative strategy to address the health workforce crisis in developing countries?. JOURNAL OF PUBLIC HEALTH, 35(1), 164-170. Author URL.

Lyons NA, Smith RP, Rushton J (2013). Cost-effectiveness of farm interventions for reducing the prevalence of VTEC O157 on UK dairy farms. EPIDEMIOLOGY AND INFECTION, 141(9), 1905-1919. Author URL.

Oppong R, Jit M, Smith RD, Butler CC, Melbye H, Mölstad S, Coast J (2013). Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. British Journal of General Practice, 63(612). Abstract.

Ghinai I, Hla TTW, Smith R (2013). Global health priorities and research funding. LANCET INFECTIOUS DISEASES, 13(8), 653-653. Author URL.

Chalkidou K, Marten R, Cutler D, Culyer T, Smith R, Teerawattananon Y, Cluzeau F, Li R, Sullivan R, Huang Y, et al (2013). Health technology assessment in universal health coverage. LANCET, 382(9910), E48-E49. Author URL.

Smith RD, Keogh-Brown MR (2013). Macroeconomic impact of pandemic influenza and associated policies in Thailand, South Africa and Uganda. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 7, 64-71. Author URL.

Hanefeld J, Horsfall D, Lunt N, Smith R (2013). Medical Tourism: a Cost or Benefit to the NHS?. PLOS ONE, 8(10). Author URL.

Tusting LS, Willey B, Lucas H, Thompson J, Kafy HT, Smith R, Lindsay SW (2013). Socioeconomic development as an intervention against malaria: a systematic review and meta-analysis. LANCET, 382(9896), 963-972. Author URL.

Rassy D, Smith RD (2013). The economic impact of H1N1 on Mexico's tourist and pork sectors. HEALTH ECONOMICS, 22(7), 824-834. Author URL.

Oppong R, Kaambwa B, Nuttall J, Hood K, Smith RD, Coast J (2013). The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 14(2), 197-209. Author URL.

Jensen HT, Keogh-Brown MR, Smith RD, Chalabi Z, Dangour AD, Davies M, Edwards P, Garnett T, Givoni M, Griffiths U, et al (2013). The importance of health co-benefits in macroeconomic assessments of UK Greenhouse Gas emission reduction strategies. CLIMATIC CHANGE, 121(2), 223-237. Author URL.

Liverani M, Waage J, Barnett T, Pfeiffer DU, Rushton J, Rudge JW, Loevinsohn ME, Scoones I, Smith RD, Cooper BS, et al (2013). Understanding and Managing Zoonotic Risk in the New Livestock Industries. ENVIRONMENTAL HEALTH PERSPECTIVES, 121(8), 873-877. Author URL.

Smith R (2012). Why a Macroeconomic Perspective is Critical to the Prevention of Noncommunicable Disease. SCIENCE, 337(6101), 1501-1503. Author URL.

Oppong R, Kaambwa B, Nuttall J, Hood K, Smith RD, Coast J, Team GS (2011). Assessment of the Construct Validity of the EQ-5D in Patients with Acute Cough/Lower Respiratory Tract Infections. APPLIED RESEARCH IN QUALITY OF LIFE, 6(4), 411-423. Author URL.

Smith RD, Keogh-Brown MR, Barnett T (2011). Estimating the economic impact of pandemic influenza: an application of the computable general equilibrium model to the UK. SOCIAL SCIENCE & MEDICINE, 73(2), 235-244. Author URL.

Alvarez MM, Chanda R, Smith RD (2011). How is Telemedicine perceived? a qualitative study of perspectives from the UK and India. GLOBALIZATION AND HEALTH, 7 Author URL.

Myint PK, Smith RD, Luben RN, Surtees PG, Wainwright NWJ, Wareham NJ, Khaw K-T (2011). Lifestyle behaviours and quality-adjusted life years in middle and older age. AGE AND AGEING, 40(5), 589-595. Author URL.

Hargreaves JR, Greenwood B, Clift C, Goel A, Roemer-Mahler A, Smith R, Heymann DL (2011). Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. LANCET, 378(9806), 1885-1893. Author URL.

Oppong R, Coast J, Hood K, Nuttall J, Smith RD, Butler CC (2011). Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 12(4), 319-329. Author URL.

Alvarez MM, Chanda R, Smith RD (2011). The potential for bi-lateral agreements in medical tourism: a qualitative study of stakeholder perspectives from the UK and India. GLOBALIZATION AND HEALTH, 7 Author URL.

Donaldson C, Baker R, Mason H, Jones-Lee M, Lancsar E, Wildman J, Bateman I, Loomes G, Robinson A, Sugden R, et al (2011). The social value of a QALY: Raising the bar or barring the raise?. BMC Health Services Research, 11

Background: Since the inception of the National Institute for Health and Clinical Excellence (NICE) in England, there have been questions about the empirical basis for the cost-per-QALY threshold used by NICE and whether QALYs gained by different beneficiaries of health care should be weighted equally. The Social Value of a QALY (SVQ) project, reported in this paper, was commissioned to address these two questions. The results of SVQ were released during a time of considerable debate about the NICE threshold, and authors with differing perspectives have drawn on the SVQ results to support their cases. As these discussions continue, and given the selective use of results by those involved, it is important, therefore, not only to present a summary overview of SVQ, but also for those who conducted the research to contribute to the debate as to its implications for NICE. Discussion. The issue of the threshold was addressed in two ways: first, by combining, via a set of models, the current UK Value of a Prevented Fatality (used in transport policy) with data on fatality age, life expectancy and age-related quality of life; and, second, via a survey designed to test the feasibility of combining respondents' answers to willingness to pay and health state utility questions to arrive at values of a QALY. Modelling resulted in values of £10,000-£70,000 per QALY. Via survey research, most methods of aggregating the data resulted in values of a QALY of £18,000-£40,000, although others resulted in implausibly high values. An additional survey, addressing the issue of weighting QALYs, used two methods, one indicating that QALYs should not be weighted and the other that greater weight could be given to QALYs gained by some groups. Summary. Although we conducted only a feasibility study and a modelling exercise, neither present compelling evidence for moving the NICE threshold up or down. Some preliminary evidence would indicate it could be moved up for some types of QALY and down for others. While many members of the public appear to be open to the possibility of using somewhat different QALY weights for different groups of beneficiaries, we do not yet have any secure evidence base for introducing such a system. © 2011 Donaldson et al; licensee BioMed Central Ltd.

Abstract. Full text.

Lorgelly PK, Coast J, Smith RD (2010). CONCEPTS OF CAPABILITY AND OVERLOOKED APPLICATIONS. AMERICAN JOURNAL OF PUBLIC HEALTH, 100(10), 1823-1824. Author URL.

Lock K, Smith RD, Dangour AD, Brown MK, Pigatto G, Hawkes C, Fisberg RM, Chalabi Z (2010). Chronic Diseases: Chronic Diseases and Development 2 Health, agricultural, and economic effects of adoption of healthy diet recommendations. LANCET, 376(9753), 1699-1709. Author URL.

Smith RD, Sach TH (2010). Contingent valuation: has the debate begun?. HEALTH ECONOMICS POLICY AND LAW, 5(1), 133-134. Author URL.

Smith RD, Petticrew M (2010). Public health evaluation in the twenty-first century: time to see the wood as well as the trees. JOURNAL OF PUBLIC HEALTH, 32(1), 2-7. Author URL.

Myint PK, Smith RD, Luben RN, Surtees PG, Wainwright NWJ, Wareham NJ, Bingham SA, Khaw K-T (2010). The Short-Form Six-Dimension utility index predicted mortality in the European Prospective Investigation into Cancer-Norfolk prospective population-based study. JOURNAL OF CLINICAL EPIDEMIOLOGY, 63(2), 192-198. Author URL.

Keogh-Brown MR, Smith RD, Edmunds JW, Beutels P (2010). The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and the Netherlands. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 11(6), 543-554. Author URL.

Smith RD, Sach TH (2009). CONTINGENT VALUATION: (STILL) ON THE ROAD TO NOWHERE?. HEALTH ECONOMICS, 18(8), 863-866. Author URL.

Nabel EG, Stevens S, Smith R (2009). Combating chronic disease in developing countries. LANCET, 373(9680), 2004-2006. Author URL.

Beutels P, Jia N, Zhou Q-Y, Smith R, Cao W-C, de Vlas SJ (2009). The economic impact of SARS in Beijing, China. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 14, 85-91. Author URL.

Smith RD, Keogh-Brown MR, Barnett T, Tait J (2009). The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment. BMJ, 339 Abstract. Author URL.

Smith RD, Chanda R, Tangcharoensathien V (2009). Trade and Health 4 Trade in health-related services. LANCET, 373(9663), 593-601. Author URL.

Smith RD, Correa C, Oh C (2009). Trade and Health 5 Trade, TRIPS, and pharmaceuticals. LANCET, 373(9664), 684-691. Author URL.

Smith RD, Lee K, Drager N (2009). Trade and Health 6 Trade and health: an agenda for action. LANCET, 373(9665), 768-773. Author URL.

Smith RD (2008). Contingent valuation in health care: Does it matter how the 'Good' is described?. HEALTH ECONOMICS, 17(5), 607-617. Author URL.

Smith R (2008). Globalization: the key challenge facing health economics in the 21st century. HEALTH ECONOMICS, 17(1), 1-3. Author URL.

Hanson K, Gilson L, Goodman C, Mills A, Smith R, Feachem R, Feachem NS, Koehlmoos TP, Kinlaw H (2008). Is Private Health Care the Answer to the Health Problems of the World's Poor?. PLOS MEDICINE, 5(11), 1528-1532. Author URL.

Beutels P, Edmunds WJ, Smith RD (2008). PARTIALLY WRONG? PARTIAL EQUILIBRIUM AND THE ECONOMIC ANALYSIS OF PUBLIC HEALTH EMERGENCIES OF INTERNATIONAL CONCERN. HEALTH ECONOMICS, 17(11), 1317-1322. Author URL.

Coast J, Smith R, Lorgelly P (2008). Should the capability approach be applied in health economics?. HEALTH ECONOMICS, 17(6), 667-670. Author URL.

Keogh-Brown MR, Smith RD (2008). The economic impact of SARS: How does the reality match the predictions?. HEALTH POLICY, 88(1), 110-120. Author URL.

Coast J, Smith RD, Lorgelly P (2008). Welfarism, extra-welfarism and capability: the spread of ideas in health economics. SOCIAL SCIENCE & MEDICINE, 67(7), 1190-1198. Author URL.

Schroter S, Black N, Evans S, Godlee F, Osorio L, Smith R (2008). What errors do peer reviewers detect, and does training improve their ability to detect them?. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 101(10), 507-514. Author URL.

Sach TH, Smith RD, Whynes DK (2007). A 'league table' of contingent valuation results for pharmaceutical interventions a hard pill to swallow?. PHARMACOECONOMICS, 25(2), 107-127. Author URL.

Holland R, Brooksby L, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, et al (2007). Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BRITISH MEDICAL JOURNAL, 334(7603), 1098-1101. Author URL.

Myint PK, Welch AA, Bingham SA, Surtees PG, Wainwright NWJ, Luben RN, Wareham NJ, Smith RD, Harvey IM, Day NE, et al (2007). Fruit and vegetable consumption and self-reported functional health in men and women in the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk): a population-based cross-sectional study. PUBLIC HEALTH NUTRITION, 10(1), 34-41. Author URL.

Smith RD, MacKellar L (2007). Global public goods and the global health agenda: problems, priorities and potential. GLOBALIZATION AND HEALTH, 3 Author URL.

Pacini M, Smith RD, Wilson ECF, Holland R (2007). Home-based medication review in older people - is it cost effective?. PHARMACOECONOMICS, 25(2), 171-180. Author URL.

Myint PK, Surtees PG, Wainwright NWJ, Wareham NJ, Bingham SA, Luben RN, Welch AA, Smith RD, Harvey IM, Khaw K-T, et al (2007). Modifiable lifestyle behaviors and functional health in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study. PREVENTIVE MEDICINE, 44(2), 109-116. Author URL.

Whynes DK, Frew EJ, Philips ZN, Covey J, Smith RD (2007). On the numerical forms of contingent valuation responses. JOURNAL OF ECONOMIC PSYCHOLOGY, 28(4), 462-476. Author URL.

Sadique MZ, Edmunds WJ, Smith RD, Meerding WJ, de Zwart O, Brug J, Beutels P (2007). Precautionary behavior in response to perceived threat of pandemic influenza. EMERGING INFECTIOUS DISEASES, 13(9), 1307-1313. Author URL.

Myint PK, Luben RN, Surtees PG, Wainwright NWJ, Welch AA, Bingham SA, Wareham NJ, Smith RD, Harvey IM, Khaw K-T, et al (2007). Self-reported mental health-related quality of life and mortality in men and women in the European prospective investigation into cancer (EPIC-Norfolk): a prospective population study. PSYCHOSOMATIC MEDICINE, 69(5), 410-414. Author URL.

Smith RD (2007). The relationship between reliability and size of willingness-to-pay values: a qualitative insight. HEALTH ECONOMICS, 16(2), 211-216. Author URL.

Smith RD (2007). The role of 'reference goods' in contingent valuation: Should we help respondents to 'construct' their willingness to pay?. HEALTH ECONOMICS, 16(12), 1319-1332. Author URL.

Yeung RYT, Smith RD, Ho L-M, Johnston JM, Leung GM (2006). Empirical implications of response acquiescence in discrete-choice contingent valuation. HEALTH ECONOMICS, 15(10), 1077-1089. Author URL.

Covey J, Smith RD (2006). How common is the 'prominence effect'? Additional evidence to Whynes et al. HEALTH ECONOMICS, 15(2), 205-210. Author URL.

Smith RD (2006). It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gain. HEALTH ECONOMICS, 15(3), 281-293. Author URL.

Smith R (2006). Measuring the globalization of health services: a possible index of openness of country health sectors to trade. HEALTH ECONOMICS POLICY AND LAW, 1(4), 323-342. Author URL.

Myint PK, Welch AA, Luben RN, Wainwright NWJ, Surtees PG, Bingham SA, Wareham NJ, Smith RD, Harvey IM, Khaw K-T, et al (2006). Obesity indices and self-reported functional health in men and women in the EPIC-Norfolk. OBESITY, 14(5), 884-893. Author URL.

Smith R, Roberts I (2006). Patient safety requires a new way to publish clinical trials. PLOS CLINICAL TRIALS, 1(1). Author URL.

Barrett A, Roques T, Small M, Smith RD (2006). Rationing - How much will Herceptin really cost?. BRITISH MEDICAL JOURNAL, 333(7578), 1118-1120A. Author URL.

Smith RD (2006). Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management. SOCIAL SCIENCE & MEDICINE, 63(12), 3113-3123. Author URL.

Smith RD (2006). Trade and public health: facing the challenges of globalisation. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 60(8), 650-651. Author URL.

Holland R, Smith R, Harvey I (2006). Where now for pharmacist led medication review?. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 60(2), 92-93. Author URL.

Smith RD, Yago M, Millar M, Coast J (2005). Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. JOURNAL OF HEALTH ECONOMICS, 24(6), 1055-1075. Author URL.

Smith RD, Richardson J (2005). Can we estimate the 'social' value of a QALY? Four core issues to resolve. HEALTH POLICY, 74(1), 77-84. Author URL.

Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, Christou M, Evans D, Hand C (2005). Does home based medication review keep older people out of hospital? the HOMER randomised controlled trial. BMJ-BRITISH MEDICAL JOURNAL, 330(7486), 293-295. Author URL.

Smith RD (2005). Sensitivity to scale in contingent valuation: the importance of the budget constraint. JOURNAL OF HEALTH ECONOMICS, 24(3), 515-529. Author URL.

Smith R, Woodward D, Acharya A, Beaglehole R, Drager N (2004). Communicable disease control: a 'Global Public Good' perspective. HEALTH POLICY AND PLANNING, 19(5), 271-278. Author URL.

Raithatha N, Smith RD (2004). Disclosure of genetic tests for health insurance: is it ethical not to?. LANCET, 363(9406), 395-396. Author URL.

Smith RD (2004). Foreign direct investment and trade in health services: a review of the literature. SOCIAL SCIENCE & MEDICINE, 59(11), 2313-2323. Author URL.

Smith RD, Thorsteinsdottir H, Daar AS, Gold ER, Singer PA (2004). Genomics knowledge and equity: a global public goods perspective of the patent system. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 82(5), 385-389. Author URL.

Raithatha N, Smith RD (2004). Paying for statins. BRITISH MEDICAL JOURNAL, 328(7436), 400-402. Author URL.

Smith RD (2003). Construction of the contingent valuation market in health care: a critical assessment. HEALTH ECONOMICS, 12(8), 609-628. Author URL.

Thorsteinsdottir H, Daar AS, Smith RD, Singer PA (2003). Genomics - a global public good?. LANCET, 361(9361), 891-892. Author URL.

Smith RD (2003). Global public goods and health. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 81(7), 475-475. Author URL.

Coast J, Smith RD (2003). Solving the problem of antimicrobial resistance: is a global approach necessary?. DRUG DISCOVERY TODAY, 8(1), 1-2. Author URL.

Smith RD, Coast J (2002). Antimicrobial resistance: a global response. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 80(2), 126-133. Author URL.

Coast J, Smith R, Karcher AM, Wilton P, Millar M (2002). Superbugs II: How should economic evaluation be conducted for interventions which aim to contain antimicrobial resistance?. HEALTH ECONOMICS, 11(7), 637-647. Author URL.

Wilton P, Smith RD, Coast J, Millar M, Karcher A (2001). Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South Africa. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 5(12), 1137-1142. Author URL.

Smith RD (2001). The relative willingness-to-pay and time-trade-off to changes in health status: an empirical investigation. HEALTH ECONOMICS, 10(6), 487-497. Author URL.

Olsen JA, Smith RD (2001). Theory versus practice: a review of 'willingness-to-pay' in health and health care. HEALTH ECONOMICS, 10(1), 39-52. Author URL.

Conferences

Miron-Shatz T, Muehlhauser I, Bower B, Diefenbach M, Goldacre B, Smith RSW, Spiegelhalter D, Wegwarth O (2011). Barriers to Health Information and Building Solutions. Author URL.

Keogh P, Jessiman P, Smith R, Wollny I, Sorhaindo A, Bonnell C (2011). THE TRIBULATIONS OF a TRIAL: EVALUATING THE TEENS AND TODDLERS TEENAGE PREGNANCY PROGRAMME. Author URL.

Holland R, Smith RD, Harvey I, Swift L, Lenaghan E (2004). Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Author URL.

Yeung RYT, Smith RD, McGhee SM (2003). Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'. Author URL.

Publications by year

In Press

2019

2018